Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-07-000202
Filing Date
2007-03-15
Accepted
2007-03-15 17:15:24
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a28300e10vk.htm 10-K 757321
2 EXHIBIT 10.25 a28300exv10w25.htm EX-10.25 33857
3 EXHIBIT 10.45 a28300exv10w45.htm EX-10.45 40806
4 EXHIBIT 10.46 a28300exv10w46.htm EX-10.46 36685
5 EXHIBIT 23.1 a28300exv23w1.htm EX-23.1 2823
6 EXHIBIT 31.1 a28300exv31w1.htm EX-31.1 8522
7 EXHIBIT 31.2 a28300exv31w2.htm EX-31.2 8515
8 EXHIBIT 32 a28300exv32.htm EX-32 4722
9 GRAPHIC a28300a2830003.gif GRAPHIC 13083
10 GRAPHIC a28300a2830001.gif GRAPHIC 10538
  Complete submission text file 0000936392-07-000202.txt   927429
Mailing Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Filer) CIK: 0001128495 (see all company filings)

EIN.: 223193172
Type: 10-K | Act: 34 | File No.: 000-50632 | Film No.: 07697287
SIC: 2834 Pharmaceutical Preparations